Last reviewed · How we verify
NCT06994962: BAMTECH
Multi-Component Breath Alcohol Intervention Phase 3
NA trial testing Alcohol-related mobile health technologies in Alcohol Use in 90 participants. Currently enrolling.
1 May 2026
Quick facts
| Lead sponsor | Northeastern University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 90 |
| Start date | 1 May 2025 |
| Primary completion | 1 May 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Alcohol-related mobile health technologies
- Motivational interview and psychoeducation on blood/breath alcohol concentration
- Lower tech facilitation
- Higher tech facilitation
- Alcohol Education
- Alcohol Education Technology
Conditions studied
- Alcohol Use — all drugs for Alcohol Use →
- Alcohol Drinking — all drugs for Alcohol Drinking →
- Drinking Behavior — all drugs for Drinking Behavior →
Sponsor
Northeastern University
Who can join
Adults 18 to 25, any sex, with Alcohol Use or Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06994962
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Alcohol-related mobile health technologies
Trials testing the same drug.
- NCT06124898 — Multi-Component Breath Alcohol Intervention · NA · active not recruiting
Other recruiting trials for Alcohol Use
Currently open trials in the same condition.
- NCT07342504 — Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist · NA · recruiting
- NCT06982443 — Wellness, Alcohol, Vitals, and Emotions · NA · recruiting
- NCT06070649 — The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD) · Phase 1 · recruiting
- NCT06736444 — Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT) · NA · recruiting
- NCT06124898 — Multi-Component Breath Alcohol Intervention · NA · active not recruiting
Other Northeastern University trials
Trials by the same sponsor.
- NCT07421830 — An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism · NA · recruiting
- NCT07147894 — Executive Function Training for Children and Adolescents · NA · recruiting
- NCT06435819 — ECA-enhanced Document Explanation RCT · NA · recruiting
- NCT07139795 — The Mind-Body Project · NA · active not recruiting
- NCT06645652 — Visual Arts Interventions With Older Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06994962 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northeastern University
- Last refreshed: 3 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06994962.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing